Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Ingestible Biosensors Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The market for ingestible biosensors has experienced rapid growth over recent years. It is anticipated to expand from $1.97 billion in 2025 to $2.18 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.6%. The historical surge in this market can be attributed to various factors, including the limitations of traditional endoscopy, a growing demand for non-invasive diagnostics, advancements in miniaturized sensors, an increase in gastrointestinal disorders, and the early adoption of capsule endoscopy.
The ingestible biosensors market size is projected to undergo significant expansion in the coming years. It is expected to achieve a value of $3.23 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This growth throughout the forecast period stems from the rise of personalized medicine, integration with mobile health platforms, an expanding elderly population, technological enhancements in data transmission, and greater clinical adoption. Prominent trends for the forecast period encompass non-invasive gastrointestinal monitoring, diagnostics based on smart capsules, real-time internal health tracking, personalized analysis of digestive health, and alternative minimally invasive diagnostic methods.
Get A Free Sample Report With In-Depth Market Insights:
Ingestible Biosensors Market Growth Backed By Core Demand Fundamentals
The ingestible biosensors market is anticipated to grow as awareness of real-time monitoring increases. Real-time monitoring entails the continuous collection, analysis, and transmission of data as it is generated, allowing for immediate health assessment and timely medical intervention. The rising awareness of real-time monitoring stems from a growing emphasis on proactive healthcare management, with patients and providers recognizing its capacity to enable early detection of health issues and prompt medical interventions. Ingestible biosensors facilitate real-time monitoring by transmitting physiological data from within the body, enabling continuous tracking of parameters like medication adherence, gastrointestinal activity, and biomarker levels for timely diagnosis and personalized treatment. For instance, in October 2024, a report from HealthArc, a U.S.-based healthcare solutions provider, stated that around 30 million patients in the U.S. were utilizing remote patient monitoring (RPM), with this number projected to climb to 70.6 million by the end of 2025. Additionally, 42 states have included RPM under Medicaid coverage, and more than 26% of Americans are expected to adopt it. Thus, the increasing awareness of real-time monitoring is propelling the growth of the ingestible biosensors market.
Ingestible Biosensors Market Segment Trends And Revenue Contributors
The ingestible biosensors market covered in this report is segmented –
1) By Product Type: Capsule Biosensors, Pill Biosensors, Other Product Types
2) By Sensor Type: Temperature Sensors, pH Sensors, Image Sensors, Other Sensor Types
3) By Application: Medical Diagnostics, Drug Delivery, Patient Monitoring, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Other End Users
Subsegments:
1) By Capsule Biosensors: Single Sensor Capsule, Multi Sensor Capsule, Smart Capsule
2) By Pill Biosensors: Diagnostic Pill, Therapeutic Pill, Monitoring Pill
3) By Other Product Types: Patch Integrated Capsule, Biodegradable Sensor, Wearable Assisted Sensor
Ingestible Biosensors Market Growth Trends Reshaping The Competitive Landscape
Major companies within the ingestible biosensors market are increasingly concentrating on developing advanced solutions, such as vitals-monitoring pills, to enhance real-time health tracking and improve early disease detection. Vitals-monitoring pills are defined as ingestible electronic capsules that monitor key physiological parameters, like heart rate, and wirelessly transmit real-time health data to external devices for monitoring and analysis. For instance, in November 2023, Celero Solutions Inc., a Canada-based information technology company, developed an ingestible electronic capsule, approximately the size of a multivitamin, capable of measuring heart and breathing rates directly from within the gastrointestinal tract. A first-in-human trial involving ten participants revealed that the device reliably detected breathing depressions, similar to those found in obstructive sleep apnea and potentially in opioid overdose scenarios. The sensor functions using an internal accelerometer and wireless transmission to capture vital-sign data and passes safely through the digestive tract without adverse effects. Researchers envision this technology being utilized for non-intrusive monitoring of respiratory status and potentially triggering interventions in high-risk patients.
Ingestible Biosensors Market Competitive Overview And Top Companies
Major companies operating in the ingestible biosensors market are Otsuka Holdings Co. Ltd., Proteus Digital Health Inc., etectRx Inc., CapsoVision Inc., IntroMedic Co. Ltd., BodyCap S.A.S., AnX Robotica Corporation, Atmo Biosciences Pty Ltd., Check-Cap Ltd., Chongqing Jinshan Science & Technology Group Co. Ltd., RF Co. Ltd., Biora Therapeutics Inc., EnteraSense Ltd., Lucid Medical Diagnostics Pvt. Ltd., Medisafe Capsule Technologies Ltd., Medtronic plc, Verily Life Sciences LLC, Olympus Corporation, JIFU Medical Technology Co. Ltd., Smart Medical Systems Ltd.
View The Full Ingestible Biosensors Market Report:
Ingestible Biosensors Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the ingestible biosensors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ingestible biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
